These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432 [TBL] [Abstract][Full Text] [Related]
3. Immune memory to Sudan virus: comparison between two separate disease outbreaks. Sobarzo A; Eskira Y; Herbert AS; Kuehne AI; Stonier SW; Ochayon DE; Fedida-Metula S; Balinandi S; Kislev Y; Tali N; Lewis EC; Lutwama JJ; Dye JM; Yavelsky V; Lobel L Viruses; 2015 Jan; 7(1):37-51. PubMed ID: 25569078 [TBL] [Abstract][Full Text] [Related]
4. Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors. Sobarzo A; Stonier SW; Herbert AS; Ochayon DE; Kuehne AI; Eskira Y; Fedida-Metula S; Tali N; Lewis EC; Egesa M; Cose S; Lutwama JJ; Yavelsky V; Dye JM; Lobel L Viruses; 2016 May; 8(5):. PubMed ID: 27187443 [TBL] [Abstract][Full Text] [Related]
5. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). Sobarzo A; Groseth A; Dolnik O; Becker S; Lutwama JJ; Perelman E; Yavelsky V; Muhammad M; Kuehne AI; Marks RS; Dye JM; Lobel L J Infect Dis; 2013 Jul; 208(2):299-309. PubMed ID: 23585686 [TBL] [Abstract][Full Text] [Related]
6. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
7. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. Thom R; Tipton T; Strecker T; Hall Y; Akoi Bore J; Maes P; Raymond Koundouno F; Fehling SK; Krähling V; Steeds K; Varghese A; Bailey G; Matheson M; Kouyate S; Coné M; Moussa Keita B; Kouyate S; Richard Ablam A; Laenen L; Vergote V; Guiver M; Timothy J; Atkinson B; Ottowell L; Richards KS; Bosworth A; Longet S; Mellors J; Pannetier D; Duraffour S; Muñoz-Fontela C; Sow O; Koivogui L; Newman E; Becker S; Sprecher A; Raoul H; Hiscox J; Henao-Restrepo AM; Sakoba K; Magassouba N; Günther S; Kader Konde M; Carroll MW Lancet Infect Dis; 2021 Apr; 21(4):507-516. PubMed ID: 33065039 [TBL] [Abstract][Full Text] [Related]
8. A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses. Wu F; Zhang S; Zhang Y; Mo R; Yan F; Wang H; Wong G; Chi H; Wang T; Feng N; Gao Y; Xia X; Zhao Y; Yang S Viruses; 2020 Jan; 12(1):. PubMed ID: 31947873 [TBL] [Abstract][Full Text] [Related]
9. A Novel Bacterium-Like Particle-Based Vaccine Displaying the SUDV Glycoprotein Induces Potent Humoral and Cellular Immune Responses in Mice. Xu S; Jiao C; Jin H; Li W; Li E; Cao Z; Shi Z; Yan F; Zhang S; He H; Chi H; Feng N; Zhao Y; Gao Y; Yang S; Wang J; Wang H; Xia X Viruses; 2019 Dec; 11(12):. PubMed ID: 31835785 [TBL] [Abstract][Full Text] [Related]
10. Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI. Radinsky O; Edri A; Brusilovsky M; Fedida-Metula S; Sobarzo A; Gershoni-Yahalom O; Lutwama J; Dye J; Lobel L; Porgador A Sci Rep; 2017 Jul; 7(1):6054. PubMed ID: 28729706 [TBL] [Abstract][Full Text] [Related]
11. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. Gunn BM; Lu R; Slein MD; Ilinykh PA; Huang K; Atyeo C; Schendel SL; Kim J; Cain C; Roy V; Suscovich TJ; Takada A; Halfmann PJ; Kawaoka Y; Pauthner MG; Momoh M; Goba A; Kanneh L; Andersen KG; Schieffelin JS; Grant D; Garry RF; Saphire EO; Bukreyev A; Alter G Immunity; 2021 Apr; 54(4):815-828.e5. PubMed ID: 33852832 [TBL] [Abstract][Full Text] [Related]
12. Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses. Gunn BM; Roy V; Karim MM; Hartnett JN; Suscovich TJ; Goba A; Momoh M; Sandi JD; Kanneh L; Andersen KG; Shaffer JG; Schieffelin JS; Garry RF; Grant DS; Alter G J Infect Dis; 2020 Jan; 221(1):156-161. PubMed ID: 31301137 [TBL] [Abstract][Full Text] [Related]
13. Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay. Sobarzo A; Perelman E; Groseth A; Dolnik O; Becker S; Lutwama JJ; Dye JM; Yavelsky V; Lobel L; Marks RS Clin Vaccine Immunol; 2012 Nov; 19(11):1844-52. PubMed ID: 22993411 [TBL] [Abstract][Full Text] [Related]